MC2590 is a potent pyridine-containing histone deacetylase (HDAC) inhibitor with selectivity for class I/IIb HDACs (HDAC1–3, -6, -8, and -10; IC₅₀ = 0.015–0.156 μM). It also inhibits other HDAC isoforms, including HDAC4, HDAC5, HDAC7, HDAC9, and HDAC11 (IC₅₀ = 1.35–3.98 μM). MC2590 induces G2/M cell cycle arrest and modulates pro-apoptotic and anti-apoptotic microRNAs to promote apoptosis.